Is renal denervation an alternative or a complement to aldosterone antagonists in treatment of resistant hypertension?

被引：2

作者：

Hamdidouche, Idir ^{[1
]}

Boutouyrie, Pierre ^{[1
]}

机构：

[1] Paris Descartes Univ, Hop Europeen Georges Pompidou, AP HP, Dept Pharmacol,INSERM UMRS970, Paris, France

来源：

JOURNAL OF HYPERTENSION | 2017年 / 35卷 / 05期

关键词：

INTENSIFIED PHARMACOTHERAPY; DOUBLE-BLIND; SPIRONOLACTONE; PLACEBO;

D O I：

10.1097/HJH.0000000000001320

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

引用

页码：955 / 957

页数：3

共 14 条

[11] Renal denervation in comparison with intensified pharmacotherapy in true resistant hypertension: 2-year outcomes of randomized PRAGUE-15 study [J].

Rosa, Jan ;

Widimsky, Petr ;

Waldauf, Petr ;

Zelinka, Tomas ;

Petrak, Ondrej ;

Taborsky, Milos ;

Branny, Marian ;

Tousek, Petr ;

Curila, Karol ;

Lambert, Lukas ;

Bednar, Frantisek ;

Holaj, Robert ;

Strauch, Branislav ;

Vaclavik, Jan ;

Kocianova, Eva ;

Nykl, Igor ;

Jiravsky, Otakar ;

Rappova, Gabriela ;

Indra, Tomas ;

Kratka, Zuzana ;

Widimsky, Jiri, Jr. .

JOURNAL OF HYPERTENSION, 2017, 35 (05) :1093-1099

[12] Randomized Comparison of Renal Denervation Versus Intensified Pharmacotherapy Including Spironolactone in True-Resistant Hypertension Six-Month Results From the Prague-15 Study [J].

Rosa, Jan ;

Widimsky, Petr ;

Tousek, Petr ;

Petrak, Ondrej ;

Curila, Karol ;

Waldauf, Petr ;

Bednar, Frantisek ;

Zelinka, Tomas ;

Holaj, Robert ;

Strauch, Branislav ;

Somloova, Zuzana ;

Taborsky, Milos ;

Vaclavik, Jan ;

Kocianova, Eva ;

Branny, Marian ;

Nykl, Igor ;

Jiravsky, Otakar ;

Widimsky, Jiri, Jr. .

HYPERTENSION, 2015, 65 (02) :407-U339

[13] Addition of Spironolactone in Patients With Resistant Arterial Hypertension (ASPIRANT) A Randomized, Double-Blind, Placebo-Controlled Trial [J].

Vaclavik, Jan ;

Sedlak, Richard ;

Plachy, Martin ;

Navratil, Karel ;

Plasek, Jiri ;

Jarkovsky, Jiri ;

Vaclavik, Tomas ;

Husar, Roman ;

Kocianova, Eva ;

Taborsky, Milos .

HYPERTENSION, 2011, 57 (06) :1069-U94

[14] Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial [J].

Williams, Bryan ;

MacDonald, Thomas M. ;

Morant, Steve ;

Webb, David J. ;

Sever, Peter ;

McInnes, Gordon ;

Ford, Ian ;

Cruickshank, J. Kennedy ;

Caulfield, Mark J. ;

Salsbury, Jackie ;

Mackenzie, Isla ;

Padmanabhan, Sandosh ;

Brown, Morris J. .

LANCET, 2015, 386 (10008) :2059-2068

← 1 2 →